-
October 27: The Week in Cancer News
Living alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’
by Kevin McLaughlin
-
Seasonal Shot Strategies
Researchers find that patients with cancer who are severely immunocompromised may benefit from a more frequent seasonal vaccine schedule.
by Sandra Gordon
-
October 20: The Week in Cancer News
Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond to chemotherapy and immunotherapy can forgo surgery.
by Thomas Celona
-
Increasing Diversity in Clinical Trials
Researchers share approaches for improving participation among underrepresented groups at AACR conference.
by Thomas Celona
-
Planning for the Return Home After Surgery
Experts suggest patients prepare for home recovery before surgery to help maintain some control.
by Coeli Carr
-
October 13: The Week in Cancer News
Rising prevalence of non-melanoma skin cancer leads to more deaths across the globe, and siblings of cancer patients struggle to ask for help.
by Eric Fitzsimmons
-
Making Treatment Decisions
It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
October 6: The Week in Cancer News
Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.
by Marci A. Landsmann
-
Fixing Systems, Building Trust
The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.
by Eric Fitzsimmons
-
Accelerating and Improving Drug Discovery
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
by Thomas Celona
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon